top of page
BPIQ Blog
Jan 19, 20212 min read
Biopharma Daily Stock Updates - 01/19/21
$XBI $154.22 (+1.64%) 📈 COVID: $GRTS (+248.51%) - Gritstone Advances Second Generation COVID-19 Vaccine “CORAL” Program with Support...
Jan 15, 20211 min read
Biopharma Daily Stock Updates - 01/15/21
$XBI $151.73 (-1.11%) 📉 PIPELINE: $AVEO (-0.37%) - AVEO Oncology Announces Results from Phase 1b Portion of DEDUCTIVE Study of Tivozanib...
Jan 14, 20211 min read
Biopharma Daily Stock Updates - 01/14/21
$XBI $153.43 (+3.27%) 📈 COVID: $VRNA (+4.64%) - Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients...
Jan 13, 20211 min read
Biopharma Daily Stock Updates - 01/13/21
$XBI $148.57 (-0.52%) 📉 PIPELINE: $ARQT (-0.66%) - Arcutis Initiates Pivotal Phase 3 Clinical Trials Evaluating Topical Roflumilast...
Jan 12, 20211 min read
Biopharma Daily Stock Updates - 01/12/21
$XBI $149.35 (+0.87%) 📈 COVID: $MRNA (+6.22%) - Swissmedic Authorizes COVID-19 Vaccine Moderna for Use in Switzerland...
Jan 11, 20211 min read
Biopharma Daily Stock Updates - 01/11/21
$XBI $148.06 (-0.99%) 📉 COVID: $HGEN (+7.61%) - Humanigen and EVERSANA Announce Partnership to Support the Launch and Commercialization...
Jan 8, 20211 min read
Biopharma Daily Stock Updates - 01/08/21
$XBI $149.54 (+0.22%) 📈 COVID: $BNTX (+7.15%) - An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that...
Jan 7, 20212 min read
Biopharma Daily Stock Updates - 01/07/21
$XBI $149.21 (+4.11%) 📈 COVID: $NVAX (+3.56%) - Novavax Finalizes Agreement with Commonwealth of Australia for 51 Million Doses of...
Jan 6, 20211 min read
Biopharma Daily Stock Updates - 01/06/21
$XBI $143.32 (+2.04%) 📈 PIPELINE: $IMRA (-37.97%) - Imara Reports Phase 2a Clinical Trial Results of IMR-687 in Adult Patients with...
Jan 5, 20211 min read
Biopharma Daily Stock Updates - 01/05/21
$XBI -0.35% 📉 COVID: $CERC (+10.61%) - Cerecor Announces Successful Proof of Concept Data for CERC-002, a Unique LIGHT-Neutralizing...
Jan 4, 20211 min read
Biopharma Daily Stock Updates - 01/04/21
$XBI $140.95 (+0.12%) 📈 COVID: $ARCT (+12.72%) - Arcturus Therapeutics Receives FDA Allowance to Proceed with Phase 2 Study of ARCT-021...
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page